ID   CCA
AC   CVCL_N717
DR   Cosmic; 687947
DR   Cosmic; 1082512
DR   Wikidata; Q54808763
RX   CelloPub=CLPUB00569;
RX   PubMed=2065319;
RX   PubMed=2516717;
RX   PubMed=8617485;
RX   PubMed=23882450;
WW   http://www.lollini.it/cca.htm
CC   Doubling time: ~90 hours (PubMed=2516717).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 12
//
RX   CelloPub=CLPUB00569;
RA   Dickman P.S., Tsokos M.G., Triche T.J.;
RT   "Biology of rhabdomyosarcoma: cell culture, xenografts, and animal
RT   models.";
RL   (In) Rhabdomyosarcoma and related tumors in children and adolescents; Maurer H.M., Ruymann F.B., Pochedly C.E. (eds.); pp.49-88; CRC Press; Boca Raton (1991).
//
RX   PubMed=2065319; DOI=10.1016/0165-4608(91)90034-R;
RA   Magnani I., Faustinella F., Nanni P., Nicoletti G., Larizza L.;
RT   "Karyotypic characterization of a new human embryonal rhabdomyosarcoma
RT   cell line.";
RL   Cancer Genet. Cytogenet. 54:83-89(1991).
//
RX   PubMed=2516717;
RA   De Giovanni C., Nanni P., Nicoletti G., Ceccarelli C., Scotlandi K.,
RA   Landuzzi L., Lollini P.-L.;
RT   "Metastatic ability and differentiative properties of a new cell line
RT   of human embryonal rhabdomyosarcoma (CCA).";
RL   Anticancer Res. 9:1943-1949(1989).
//
RX   PubMed=8617485; DOI=10.1016/S0046-8177(96)90115-X;
RA   Scotlandi K., Serra M., Manara M.C., Benini S., Sarti M., Maurici D.,
RA   Lollini P.-L., Picci P., Bertoni F., Baldini N.;
RT   "Immunostaining of the p30/32MIC2 antigen and molecular detection of
RT   EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral
RT   neuroectodermal tumor.";
RL   Hum. Pathol. 27:408-416(1996).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//